CTCFL or BORIS (Brother of the Regulator of Imprinted Sites), a paralog of CTCF, has been classified as a cancer-testis antigen as its distribution is reported to be limited to the testis and certain cancers [1]. This evidence concerns the gene CTCFL and cancer.